Valneva SE (VALN) Equity Income (2021 - 2025)

Valneva SE (VALN) reported Equity Income of -$58.2 million for Q4 2025, down 47.6% on a YoY basis from -$111.1 million in Q4 2024, and down 12.13% sequentially from -$51.9 million in Q3 2025.

Valneva SE (VALN) Equity Income (2021 - 2025) Analysis & Trends

Valneva SE (VALN) has 3 years of Equity Income data on file, last reported at -$58.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Equity Income fell 47.6% year-over-year to -$58.2 million; the trailing twelve-month figure through Dec 2025 stood at -$159.8 million (down 3.91% YoY), and the FY2025 full-year result was -$134.1 million, down 915.54% from the prior year.
  • Equity Income slipped to -$58.2 million in Q4 2025, from -$51.9 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$10.2 million in Q3 2024 to a low of -$70.7 million in Q2 2021.
  • A 3-year average of -$44.0 million and a median of -$45.7 million in 2025 frame the typical range for Equity Income.
  • Peak annual rise in Equity Income reached 47.6% in 2025, while the deepest fall reached 408.21% in 2025.
  • Tracing VALN's Equity Income over 3 years: stood at -$70.7 million in 2021, then jumped by 44.22% to -$39.4 million in 2024, then sank by 47.6% to -$58.2 million in 2025.
  • Business Quant data shows VALN's Equity Income at -$58.2 million in Q4 2025, -$51.9 million in Q3 2025, and -$39.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Valneva SE 811.46 Mn 688.23 Mn 5.08 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -58.20 Mn
Sep 30, 2025 -51.91 Mn
Dec 31, 2024 -39.43 Mn
Sep 30, 2024 -10.21 Mn
Jun 30, 2021 -70.69 Mn
Mar 31, 2021 -33.41 Mn